Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 13, 2014 - Issue 7
Submit an article Journal homepage
1,735
Views
58
CrossRef citations to date
0
Altmetric
Reviews

Risk versus risk: a review of benzodiazepine reduction in older adults

Allison M PaquinVA Boston Healthcare System (VABHS), Boston, MA, USA+1 617 794 6401; [email protected]
, PharmD,
Kristin ZimmermanMassachusetts College of Pharmacy and Health Sciences, Boston, MA, USA
, PharmD CGP &
James L RudolphVA Boston Healthcare System (VABHS), Geriatric Research Education and Clinical Center (GRECC), Boston, MA, USA;Chief (interim), VA Boston Healthcare System (VABHS), Section of Geriatrics and Palliative Care, Boston, MA, USA;Associate Professor, Harvard Medical School, Boston, MA, USA
, MD SM
Pages 919-934 | Published online: 06 Jun 2014

Citations (58)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Mojtaba Vaismoradi, Shazia Jamshed, Stefan Lorenzl & Piret Paal. (2021) PRN Medicines Management for Older People with Long-Term Mental Health Disorders in Home Care. Risk Management and Healthcare Policy 14, pages 2841-2849.
Read now
Lynsey Seim, Priyanka Vijapura, Sandeep Pagali & M Caroline Burton. (2020) Common substance use disorders in older adults. Hospital Practice 48:sup1, pages 48-55.
Read now
Tauheed Zaman, Tessa L. Rife, Steven L. Batki & David L. Pennington. (2018) An electronic intervention to improve safety for pain patients co-prescribed chronic opioids and benzodiazepines. Substance Abuse 39:4, pages 441-448.
Read now
Emily Reeve, Frank Moriarty, Rayan Nahas, Justin P. Turner, Lisa Kouladjian O’Donnell & Sarah N. Hilmer. (2018) A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms. Expert Opinion on Drug Safety 17:1, pages 39-49.
Read now

Articles from other publishers (54)

Karn Chahal, Matthew Glass, Jamie Falk, Alexander Singer & Christine Leong. (2023) Patient values and preferences regarding communicating risk versus benefit of benzodiazepine initiation: A cross‐sectional survey study. Health Science Reports 6:12.
Crossref
Nathaniel F. Watson, Ruth M. Benca, Andrew D. Krystal, William V. McCall & David N. Neubauer. (2023) Alliance for Sleep Clinical Practice Guideline on Switching or Deprescribing Hypnotic Medications for Insomnia. Journal of Clinical Medicine 12:7, pages 2493.
Crossref
Joshua Niznik, Stefanie P. Ferreri, Lori Armistead, Benjamin Urick, Mary-Haston Vest, Liang Zhao, Tamera Hughes, J. Marvin McBride & Jan Busby-Whitehead. (2022) A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial. Trials 23:1.
Crossref
Savannah Gerardi, David Sperlea, Shirel Ora-Lee Levy, Kaitlin Bondurant-David, Sébastien Dang, Pierre-Marie David, Annie Lizotte, Lysane Senécal, François Paquette & Marie-Claude Vanier. (2022) Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis. American Journal of Health-System Pharmacy 79:Supplement_4, pages S128-S135.
Crossref
Deborah Dowell, Kathleen R. Ragan, Christopher M. Jones, Grant T. Baldwin & Roger Chou. (2022) CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 . MMWR. Recommendations and Reports 71:3, pages 1-95.
Crossref
Julie C. Lauffenburger, Maxwell D. Coll, Erin Kim, Ted Robertson, Rebecca Oran, Nancy Haff, Kaitlin Hanken, Jerry Avorn & Niteesh K. Choudhry. (2022) Prescribing decision making by medical residents on night shifts: A qualitative study. Medical Education 56:10, pages 1032-1041.
Crossref
Glenna S. Brewster, Barbara Riegel & Philip R. Gehrman. (2022) Insomnia in the Older Adult. Sleep Medicine Clinics 17:2, pages 233-239.
Crossref
Barbara Farrell. (2022) Part I: Interactive case: Rational deprescribing of benzodiazepine receptor agonists for insomnia. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 5:3, pages 370-376.
Crossref
François-Xavier Sibille, Anne Spinewine, Lorène Zerah, Laurentine Maljean, Didier Schoevaerdts & Marie de Saint-Hubert. (2022) Current practice in benzodiazepine receptor agonists deprescribing on acute geriatric wards: a cohort study. BMC Geriatrics 22:1.
Crossref
Allison R. Thompson, Catherine S. Kim, Grace E. Kim, Michelle S. Keller, Zachary A. Marcum & Nicole J. Brandt. (2022) Challenges and Successes of Global Deprescribing Networks: A Qualitative Key Informant Study. Journal of Gerontological Nursing 48:1, pages 7-14.
Crossref
Alistair J. Reid Finlayson, Jane Macoubrie, Christy Huff, D.E. Foster & Peter R. Martin. (2022) Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey. Therapeutic Advances in Psychopharmacology 12, pages 204512532210823.
Crossref
Michael Soyka. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 494 509 .
Hana Vankova, Iva Holmerova & Ladislav Volicer. (2021) Geriatric Depression and Inappropriate Medication: Benefits of Interprofessional Team Cooperation in Nursing Homes. International Journal of Environmental Research and Public Health 18:23, pages 12438.
Crossref
Jaden Brandt, Donica Janzen, Silvia Alessi-Severini, Alexander Singer, Dan Chateau, Murray Enns & Christine Leong. (2021) Risk of long-term benzodiazepine and Z-drug use following the first prescription among community-dwelling adults with anxiety/mood and sleep disorders: a retrospective cohort study. BMJ Open 11:11, pages e046916.
Crossref
Mélinée Chapoutot, Laure Peter-Derex, Hélène Bastuji, Wendy Leslie, Benjamin Schoendorff, Raphael Heinzer, Francesca Siclari, Alain Nicolas, Patrick Lemoine, Susan Higgins, Alexia Bourgeois, Guillaume T. Vallet, Royce Anders, Marc Ounnoughene, Jessica Spencer, Francesca Meloni & Benjamin Putois. (2021) Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders. International Journal of Environmental Research and Public Health 18:19, pages 10222.
Crossref
Michael Soyka. (2021) Missbrauch und Abhängigkeit von Benzodiazepinen und Z-Drugs. Nervenheilkunde 40:08, pages 636-647.
Crossref
Shelly L. Gray, Zizi Elsisi, Elizabeth A. Phelan & Joseph T. Hanlon. (2021) Interventions to Reduce Fall-Risk-Increasing Drug Use to Prevent Falls: A Narrative Review of Randomized Trials. Drugs & Aging 38:4, pages 301-309.
Crossref
Robert William Hoel, Ryan M. Giddings Connolly & Paul Y. Takahashi. (2021) Polypharmacy Management in Older Patients. Mayo Clinic Proceedings 96:1, pages 242-256.
Crossref
Mara Storto & Meera Balasubramaniam. 2021. Absolute Geriatric Psychiatry Review. Absolute Geriatric Psychiatry Review 259 269 .
Laura A. Hart, Elizabeth A. Phelan, Julia Y. Yi, Zachary A. Marcum & Shelly L. Gray. (2020) Use of Fall Risk–Increasing Drugs Around a Fall‐Related Injury in Older Adults: A Systematic Review. Journal of the American Geriatrics Society 68:6, pages 1334-1343.
Crossref
Jeffrey Gold. (2020) Approaches to managing benzodiazepines. Pharmacy Today 26:3, pages 41-54.
Crossref
Laura J Anderson, Jeffrey L Schnipper, Teryl K Nuckols, Rita Shane, Catherine Sarkisian, Michael M Le, Joshua M Pevnick, Carmel M Hughes, Cynthia A Jackevicius & Denis O’Mahony. (2019) A systematic overview of systematic reviews evaluating interventions addressing polypharmacy. American Journal of Health-System Pharmacy 76:21, pages 1777-1787.
Crossref
Roy R. Reeves & Arif Kamal. (2019) Complicated Withdrawal Phenomena During Benzodiazepine Cessation in Older Adults. Journal of Osteopathic Medicine 119:5, pages 327-331.
Crossref
Vera De Carlo, Benedetta Grancini, Matteo Vismara, Beatrice Benatti, Chiara Arici, Laura Cremaschi, Giovanna Cirnigliaro, Luca Degoni, Lucio Oldani, Carlotta Palazzo, Ira D. Glick, Caterina Viganò & Bernardo Dell'Osso. (2019) Exploring characteristics associated with first benzodiazepine prescription in patients with affective disorders and related diagnoses. Human Psychopharmacology: Clinical and Experimental 34:3, pages e2695.
Crossref
D. A. Sychev, A. V. Zhuchkov, O. V. Tereshchenko & D. V. Ivashchenko. (2019) Tapering (deprescribing) of benzodiazepine tranquilizers. Neurology, Neuropsychiatry, Psychosomatics 11:1, pages 89-95.
Crossref
Ritva Lähteenmäki, Pertti J. Neuvonen, Juha Puustinen, Tero Vahlberg, Markku Partinen, Ismo Räihä & Sirkka‐Liisa Kivelä. (2018) Withdrawal from long‐term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia. Basic & Clinical Pharmacology & Toxicology 124:3, pages 330-340.
Crossref
. (2018) Take a multifaceted stepwise approach when deprescribing benzodiazepines in older patients. Drugs & Therapy Perspectives 35:2, pages 72-76.
Crossref
Stephanie L. Harrison, Monica Cations, Tiffany Jessop, Sarah N. Hilmer, Mouna Sawan & Henry Brodaty. (2018) Approaches to Deprescribing Psychotropic Medications for Changed Behaviours in Long-Term Care Residents Living with Dementia. Drugs & Aging 36:2, pages 125-136.
Crossref
Lisa M. Kalisch Ellett, Renly Lim, Nicole L. Pratt, Mhairi Kerr, Emmae N. Ramsay, Tammy V. LeBlanc, John D. Barratt & Elizabeth E. Roughead. (2018) Reducing hypnotic use in insomnia management among Australian veterans: results from repeated national interventions. BMC Health Services Research 18:1.
Crossref
Juha Puustinen, Ritva Lähteenmäki, Janne Nurminen, Tero Vahlberg, Pertti Aarnio, Markku Partinen, Ismo Räihä, Pertti J. Neuvonen & Sirkka-Liisa Kivelä. (2018) Long-term persistence of withdrawal of temazepam, zopiclone, and zolpidem in older adults: a 3-year follow-up study. BMC Geriatrics 18:1.
Crossref
François Naccache & Florence Vorspan. (2018) Stratégies de sevrage de benzodiazépines en ambulatoire. Revue de la littérature. La Presse Médicale 47:10, pages 899-912.
Crossref
Florence Vorspan, Thomas Barré, Antoine Pariente, François Montastruc & Marie Tournier. (2018) Faut-il limiter la durée des traitements par benzodiazépines ?. La Presse Médicale 47:10, pages 892-898.
Crossref
Marie-Michèle Tanguay Bernard, Mireille Luc, Jean-Daniel Carrier, Louise Fournier, Arnaud Duhoux, Elodie Côté, Olivier Lessard, Catherine Gibeault, Christian Bocti & Pasquale Roberge. (2018) Patterns of benzodiazepines use in primary care adults with anxiety disorders. Heliyon 4:7, pages e00688.
Crossref
Mina Kobayashi, Isa Okajima, Hajime Narisawa, Takashi Kikuchi, Kentaro Matsui, Ken Inada, Jun Ishigooka & Yuichi Inoue. (2018) Development of a new benzodiazepine hypnotics withdrawal symptom scale. Sleep and Biological Rhythms 16:3, pages 263-271.
Crossref
Brendan J. Ng, David G. Le Couteur & Sarah N. Hilmer. (2018) Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients. Drugs & Aging 35:6, pages 493-521.
Crossref
Glenna S. Brewster, Barbara Riegel & Philip R. Gehrman. (2018) Insomnia in the Older Adult. Sleep Medicine Clinics 13:1, pages 13-19.
Crossref
Gina C. Dobbs & Susanne A. Fogger. (2018) Opiate Dependence or Addiction?. Journal of Addictions Nursing 29:1, pages 57-61.
Crossref
Monica Martinez-Cengotitabengoa, Maria Jose Diaz-Gutierrez, Ariadna Besga, Cristina Bermúdez-Ampudia, Purificación López, Marta B. Rondon, Donna E. Stewart, Patricia Perez, Miguel Gutierrez & Ana Gonzalez-Pinto. (2018) Benzodiazepine prescriptions and falls in older men and women. Revista de Psiquiatría y Salud Mental (English Edition) 11:1, pages 12-18.
Crossref
Monica Martinez-Cengotitabengoa, Maria Jose Diaz-Gutierrez, Ariadna Besga, Cristina Bermúdez-Ampudia, Purificación López, Marta B. Rondon, Donna E. Stewart, Patricia Perez, Miguel Gutierrez & Ana Gonzalez-Pinto. (2018) Prescripción de benzodiacepinas y caídas en mujeres y hombres ancianos. Revista de Psiquiatría y Salud Mental 11:1, pages 12-18.
Crossref
Tilman Wetterling & Klaus Junghanns. (2017) Substance Abuse in Older Psychiatric Inpatients. SUCHT 63:2, pages 115-121.
Crossref
Dirk K. Wolter. (2017) Suchtpotenzial und andere Risiken von Benzodiazepinen und Z-Drugs im Alter. SUCHT 63:2, pages 81-97.
Crossref
Emily Reeve, Wade Thompson & Barbara Farrell. (2017) Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. European Journal of Internal Medicine 38, pages 3-11.
Crossref
Dirk K. Wolter. (2017) Benzodiazepine absetzen im AlterDiscontinuation of benzodiazepines in old age. Zeitschrift für Gerontologie und Geriatrie 50:2, pages 115-122.
Crossref
David J. Kim & Srdjan S. Nedeljkovic. 2017. Pain Medicine. Pain Medicine 173 174 .
A.J.-P. Schwitzguébel, C. Benaïm, S. Carda, A.M. Torea Filgueira, R. Frischknecht & P.-A. Rapin. (2016) GABAergic drug use and global, cognitive, and motor functional outcomes after stroke. Annals of Physical and Rehabilitation Medicine 59:5-6, pages 320-325.
Crossref
Matej Markota, Teresa A. Rummans, John Michael Bostwick & Maria I. Lapid. (2016) Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies. Mayo Clinic Proceedings 91:11, pages 1632-1639.
Crossref
Guillaume Airagnes, Antoine Pelissolo, Mélanie Lavallée, Martine Flament & Frédéric Limosin. (2016) Benzodiazepine Misuse in the Elderly: Risk Factors, Consequences, and Management. Current Psychiatry Reports 18:10.
Crossref
Paxton BachGeoffrey WaltonKanna HayashiM-J MilloyHuiru DongThomas KerrJulio MontanerEvan Wood. (2016) Benzodiazepine Use and Hepatitis C Seroconversion in a Cohort of Persons Who Inject Drugs. American Journal of Public Health 106:6, pages 1067-1072.
Crossref
Daniele Cristina Comino Naloto, Francine Cristiane Lopes, Silvio Barberato Filho, Luciane Cruz Lopes, Fernando de Sá Del Fiol & Cristiane de Cássia Bergamaschi. (2016) Prescrição de benzodiazepínicos para adultos e idosos de um ambulatório de saúde mental. Ciência & Saúde Coletiva 21:4, pages 1267-1276.
Crossref
Deborah Dowell, Tamara M. Haegerich & Roger Chou. (2016) CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016. MMWR. Recommendations and Reports 65:1, pages 1-49.
Crossref
Vincenzo Arcoraci & Edoardo Spina. 2016. Pharmacovigilance in Psychiatry. Pharmacovigilance in Psychiatry 191 207 .
Angela Wright, Jacqueline Diebold, Jaskiran Otal, Carly Stoneman, Jonathan Wong, Christine Wallace & Mark Duffett. (2015) The Effect of Melatonin on Benzodiazepine Discontinuation and Sleep Quality in Adults Attempting to Discontinue Benzodiazepines: A Systematic Review and Meta-Analysis. Drugs & Aging 32:12, pages 1009-1018.
Crossref
Caterina Vicens Caldentey, Ermengol Sempere Verd?Francisca Fiol Gelabert. (2015) Estrategias para reducir el uso prolongado de benzodiacepinas. FMC - Formaci?n M?dica Continuada en Atenci?n Primaria 22:9, pages 510-518.
Crossref
Lamiae Grimaldi-Bensouda, Lucien Abenhaim, Jacques Massol, Didier Guillemot, Bernard Avouac, Gerard Duru, France Lert, Anne-Marie Magnier, Michel Rossignol, Frederic Rouillon & Bernard Begaud. (2015) Utilization of psychotropic drugs by patients consulting for sleeping disorders in homeopathic and conventional primary care settings: the EPI3 cohort study. Homeopathy 104:3, pages 170-175.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.